After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Pacira BioSciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Pacira BioSciences Inc is $920.24M. A total of 0.7 million shares were traded on the day, compared to an average of 778.18K shares.
In the most recent transaction, GAUGLER DARYL sold 500 shares of PCRX for 19.76 per share on Dec 13 ’24. After the transaction, the Chief Operating Officer now owns 115,200 company shares. In a previous transaction on Dec 13 ’24, GAUGLER DARYL bought 500 shares at 19.76 per share.
Among the insiders who sold shares, GAUGLER DARYL disposed of 500 shares on Sep 13 ’24 at a per-share price of $12.86. This resulted in the Chief Operating Officer holding 115,700 shares of PCRX after the transaction. In another insider transaction, GAUGLER DARYL bought 500 shares at $12.86 per share on Sep 13 ’24.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, PCRX has a high of $35.95 and a low of $11.16.
As of this writing, PCRX has an earnings estimate of $0.79 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.91 per share and a lower estimate of $0.57.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. PCRX’s latest balance sheet shows that the firm has $656.41M in Cash & Short Term Investments as of fiscal 2021. There were $1.13B in debt and $521.12M in liabilities at the time. Its Book Value Per Share was $16.24, while its Total Shareholder’s Equity was $730.41M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCRX is Buy with a score of 3.11.
